STOCK TITAN

[Form 4] Addus HomeCare Corp Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Heather Brianne Dixon, a named officer of Addus HomeCare Corp (ADUS), reported an acquisition on 09/15/2025 of 28,370 shares of the issuer's common stock at a reported price of $0. Following the reported transaction, Ms. Dixon beneficially owns 32,189 shares, held directly. The filing includes an explanatory note that the newly reported shares vest in equal installments on September 15, 2026, September 15, 2027, and September 15, 2028, subject to customary continued-service provisions and acceleration on a change in control. The Form 4 was signed by an attorney-in-fact on 09/16/2025.

Heather Brianne Dixon, un ufficiale nominato di Addus HomeCare Corp (ADUS), ha riferito un'acquisizione il 15/09/2025 di 28.370 azioni ordinarie dell'emittente a un prezzo riportato di $0. Dopo la transazione riportata, la Signora Dixon detiene beneficiariamente 32.189 azioni, detenute direttamente. L'invio contiene una nota esplicativa secondo cui le nuove azioni riportate vestono in rate uguali il 15 settembre 2026, 15 settembre 2027 e 15 settembre 2028, soggette alle consuete disposizioni di continuo servizio e all'accelerazione in caso di cambiamento di controllo. Il Form 4 è stato firmato da un procuratore in data 16/09/2025.

Heather Brianne Dixon, una funcionaria nombrada de Addus HomeCare Corp (ADUS), reportó una adquisición el 15/09/2025 de 28,370 acciones ordinarias del emisor a un precio informado de $0. Tras la transacción reportada, la Sra. Dixon posee beneficiosamente 32,189 acciones, gestionadas directamente. La presentación incluye una nota explicativa que las nuevas acciones reportadas vestirán en cuotas iguales los 15 de septiembre de 2026, 15 de septiembre de 2027 y 15 de septiembre de 2028, sujeto a disposiciones habituales de servicio continuo y aceleración ante un cambio de control. El Formulario 4 fue firmado por un mandatario en fecha 16/09/2025.

Heather Brianne Dixon은 Addus HomeCare Corp(ADUS)의 지정 임원으로서, 2025년 9월 15일에 발행사 보통주 28,370주를 보고된 가격 $0에 취득했다고 보고했습니다. 보고된 거래 이후 Dixon은 32,189주를 직접 소유합니다. 제출 서류에는 새로 보고된 주식이 2026년 9월 15일, 2027년 9월 15일, 2028년 9월 15일에 균등 분할 vesting 되며, 일반적인 계속 근무 조항과 지배 변경 시 가속화에 따른 조건이 함유되어 있습니다. Form 4는 2025년 9월 16일에 대리인이 서명했습니다.

Heather Brianne Dixon, une dirigeante désignée de Addus HomeCare Corp (ADUS), a signalé une acquisition le 15/09/2025 de 28 370 actions ordinaires de l'émetteur à un prix déclaré de $0. Suite à la transaction reportée, Mme Dixon détient bénéficiairement 32 189 actions, détenues directement. Le dépôt comprend une note explicative indiquant que les nouvelles actions rapportées vestiront par versements égaux les 15 septembre 2026, 15 septembre 2027 et 15 septembre 2028, sous réserve des dispositions habituelles de continuité du service et d'une accélération en cas de changement de contrôle. Le Formulaire 4 a été signé par un mandataire le 16/09/2025.

Heather Brianne Dixon, eine benannte Beamtin von Addus HomeCare Corp (ADUS), meldete am 15.09.2025 einen Erwerb von 28.370 Stammaktien des Emittenten zu einem gemeldeten Preis von $0. Nach der gemeldeten Transaktion besitzt Frau Dixon vorteilhaft 32.189 Aktien, direkt gehalten. Die Einreichung enthält eine erläuternde Notiz, dass die neu gemeldeten Aktien in gleichen Raten am 15. September 2026, 15. September 2027 und 15. September 2028 vesten, vorbehaltlich üblicher fortlaufender Servicebestimmungen und einer Beschleunigung bei einer Kontrollwechsel. Das Formular 4 wurde von einem Bevollmächtigten am 16.09.2025 unterschrieben.

هيلتر بريان دنيس، موظفة مذكورة في Addus HomeCare Corp (ADUS)، أبلغت عن شراء في 15/09/2025 لعدد 28,370 من أسهم الشركة العادية بسعر يبلغ $0. بعد الصفقة كما ورد، تملك السيدة دینس مفيداً 32,189 سهماً، مملوكة مباشرة. يتضمن الملف ملاحظة توضيحية بأن الأسهم المبلغ عنها حديثاً ستُ vest بالتقسيط المتساوي في 15 سبتمبر 2026، 15 سبتمبر 2027 و15 سبتمبر 2028، رهناً بالأحكام المعتادة للخدمة المستمرة وبالتسريع عند حدوث تغيّر في السيطرة. تم توقيع النموذج 4 من قبل نائب مفوض في تاريخ 16/09/2025.

Heather Brianne Dixon,Addus HomeCare Corp(ADUS)的指定官员,报告于2025年9月15日以披露价<$0购买了发行人普通股28,370股。交易后,Dixon女士直接持有32,189股受益所有权。 filing includes an explanatory note that the newly reported shares vest in equal installments on 2026-09-15, 2027-09-15, 2028-09-15,并受常规持续服务条款以及在控股变更时的加速条款约束。Form 4由一名代理律师于2025-09-16签署。

Positive
  • Acquisition of 28,370 shares reported (transaction code A), increasing direct beneficial ownership to 32,189 shares
  • Vesting schedule disclosed: shares vest in equal installments on Sep 15, 2026, Sep 15, 2027, and Sep 15, 2028
  • Change-in-control acceleration is disclosed, clarifying terms of the equity award
Negative
  • None.

Insights

TL;DR: Officer reported a sizeable grant/vesting of 28,370 shares that increases direct ownership to 32,189 shares.

The Form 4 discloses a non-cash acquisition (transaction code A) of 28,370 common shares at a reported price of $0, consistent with an equity award or grant rather than an open-market purchase. The shares are subject to time-based vesting over three annual installments and include acceleration on a change in control, which is typical for retention and alignment purposes. For investors, this is a routine executive equity grant disclosure; it changes the officer's direct stake but contains no cash proceeds or debt impact for the company.

TL;DR: Filing documents a standard restricted-equity grant with multi-year vesting and change-in-control acceleration.

The explanatory note confirms the award vests in equal installments over three years and includes customary acceleration on a change in control. The structure indicates retention incentives and potential alignment of management with shareholder outcomes without immediate dilutionary cash impact. The report is filed by a single reporting person and signed by an attorney-in-fact, satisfying procedural reporting requirements. No unusual terms or immediate insider sales are disclosed.

Heather Brianne Dixon, un ufficiale nominato di Addus HomeCare Corp (ADUS), ha riferito un'acquisizione il 15/09/2025 di 28.370 azioni ordinarie dell'emittente a un prezzo riportato di $0. Dopo la transazione riportata, la Signora Dixon detiene beneficiariamente 32.189 azioni, detenute direttamente. L'invio contiene una nota esplicativa secondo cui le nuove azioni riportate vestono in rate uguali il 15 settembre 2026, 15 settembre 2027 e 15 settembre 2028, soggette alle consuete disposizioni di continuo servizio e all'accelerazione in caso di cambiamento di controllo. Il Form 4 è stato firmato da un procuratore in data 16/09/2025.

Heather Brianne Dixon, una funcionaria nombrada de Addus HomeCare Corp (ADUS), reportó una adquisición el 15/09/2025 de 28,370 acciones ordinarias del emisor a un precio informado de $0. Tras la transacción reportada, la Sra. Dixon posee beneficiosamente 32,189 acciones, gestionadas directamente. La presentación incluye una nota explicativa que las nuevas acciones reportadas vestirán en cuotas iguales los 15 de septiembre de 2026, 15 de septiembre de 2027 y 15 de septiembre de 2028, sujeto a disposiciones habituales de servicio continuo y aceleración ante un cambio de control. El Formulario 4 fue firmado por un mandatario en fecha 16/09/2025.

Heather Brianne Dixon은 Addus HomeCare Corp(ADUS)의 지정 임원으로서, 2025년 9월 15일에 발행사 보통주 28,370주를 보고된 가격 $0에 취득했다고 보고했습니다. 보고된 거래 이후 Dixon은 32,189주를 직접 소유합니다. 제출 서류에는 새로 보고된 주식이 2026년 9월 15일, 2027년 9월 15일, 2028년 9월 15일에 균등 분할 vesting 되며, 일반적인 계속 근무 조항과 지배 변경 시 가속화에 따른 조건이 함유되어 있습니다. Form 4는 2025년 9월 16일에 대리인이 서명했습니다.

Heather Brianne Dixon, une dirigeante désignée de Addus HomeCare Corp (ADUS), a signalé une acquisition le 15/09/2025 de 28 370 actions ordinaires de l'émetteur à un prix déclaré de $0. Suite à la transaction reportée, Mme Dixon détient bénéficiairement 32 189 actions, détenues directement. Le dépôt comprend une note explicative indiquant que les nouvelles actions rapportées vestiront par versements égaux les 15 septembre 2026, 15 septembre 2027 et 15 septembre 2028, sous réserve des dispositions habituelles de continuité du service et d'une accélération en cas de changement de contrôle. Le Formulaire 4 a été signé par un mandataire le 16/09/2025.

Heather Brianne Dixon, eine benannte Beamtin von Addus HomeCare Corp (ADUS), meldete am 15.09.2025 einen Erwerb von 28.370 Stammaktien des Emittenten zu einem gemeldeten Preis von $0. Nach der gemeldeten Transaktion besitzt Frau Dixon vorteilhaft 32.189 Aktien, direkt gehalten. Die Einreichung enthält eine erläuternde Notiz, dass die neu gemeldeten Aktien in gleichen Raten am 15. September 2026, 15. September 2027 und 15. September 2028 vesten, vorbehaltlich üblicher fortlaufender Servicebestimmungen und einer Beschleunigung bei einer Kontrollwechsel. Das Formular 4 wurde von einem Bevollmächtigten am 16.09.2025 unterschrieben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Dixon Heather Brianne

(Last) (First) (Middle)
6303 COWBOYS WAY
SUITE 600

(Street)
FRISCO TX 75034

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Addus HomeCare Corp [ ADUS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
President and Chief Operating
3. Date of Earliest Transaction (Month/Day/Year)
09/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/15/2025 A 28,370(1) A $0 32,189 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The shares vest in equal installments on each of September 15, 2026, September 15, 2027, and September 15, 2028, subject to customary provisions for continued service and acceleration on a change in control.
/s/ Brian Poff, Attorney-In-Fact for Heather Brianne Dixon 09/16/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Heather Brianne Dixon report on Form 4 for ADUS?

The Form 4 reports an acquisition of 28,370 common shares on 09/15/2025 at a reported price of $0, increasing her direct beneficial ownership to 32,189 shares.

Are the acquired ADUS shares immediately vested?

No. The filing states the shares vest in equal installments on September 15, 2026, September 15, 2027, and September 15, 2028, subject to continued service and change-in-control acceleration.

What does a reported price of $0 indicate on this Form 4?

A price of $0 in this filing indicates the reported acquisition was not a market purchase and is consistent with an equity award or grant rather than a cash purchase.

Who signed the Form 4 filing for Heather Brianne Dixon?

The Form 4 was signed by Brian Poff, Attorney-In-Fact for Heather Brianne Dixon, on 09/16/2025.

Does this Form 4 show any insider sales by the reporting person?

No. The filing shows an acquisition (code A) of shares and does not report any dispositions or sales.
Addus Homecare Corp

NASDAQ:ADUS

ADUS Rankings

ADUS Latest News

ADUS Latest SEC Filings

ADUS Stock Data

2.13B
17.93M
2.46%
104.29%
3.45%
Medical Care Facilities
Services-home Health Care Services
Link
United States
FRISCO